Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 7/20 | 0.42 |
| ▸ | RARB | P10826 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | RARA | P10276 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6518926 | 0.91 | FAAH (0.48) | TSHRRECQLFAAHLMNA | |
| SCHEMBL6523796 | 0.91 | GAA (0.40) | TSHRRECQLRARBKDM4ELMNA | |
| SCHEMBL6520970 | 0.88 | FAAH (0.49) | TSHRFAAHLMNANPC1RAB9A | |
| SCHEMBL6520862 | 0.88 | FAAH (0.49) | TSHRFAAHLMNANPC1RAB9A | |
| SCHEMBL6514468 | 0.86 | SMN1; SMN2 (0.43) | TSHRRECQLFAAHKMT2ALTA4H | |
| SCHEMBL6520630 | 0.85 | PPARG (0.40) | MEN1KMT2AGAA | |
| SCHEMBL6516142 | 0.85 | TSHR (0.41) | TSHRRECQLRARBLMNAMEN1 | |
| SCHEMBL6518687 | 0.84 | TSHR (0.40) | TSHRRECQLKDM4ELMNAMEN1 | |
| SCHEMBL6520822 | 0.84 | FAAH (0.40) | TSHRFAAHLMNANPC1 | |
| SCHEMBL6519432 | 0.83 | FAAH (0.39) | TSHRFAAHRARBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | TSHR 3581/4885RECQL 2058/4885FAAH 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.